Rxsight
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 Columbia, Aliso Viejo, California, 9...Phone Number
(949) 521-7830Website
www.rxsight.comRevenue
$127.5 MillionStock Symbol
RXSTIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Rxsight
RxSight enables doctors and patients to predictably optimize vision after cataract surgery through an office-based IOL enhancement. RxSight was founded in 1997 and is headquartered in California.Explore more
Rxsight Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rxsight your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Rxsight had a recent Job posting/layoffs
Check out if Rxsight is spiking on competitors!
Check if Rxsight has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Rxsight has new funding data
Rxsight, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Rxsight recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rxsight launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Rxsight
Recommended Actions
Find VP level buyers at Rxsight
Find 3 more new buyers
Compare Similar Companies to Rxsight
Compare insights from companies similar to Rxsight, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rxsight is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rxsight is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rxsight.
Rxsight financials insights
Gather financial insights about Rxsight, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Private Equity
$8.5M
2011
Private Equity
$12.7M
2015
Debt
$17M
Private Equity
$52M
2017
Private Equity
$50M
2020
Debt
$60M
2021
Share Placement
$117.6M
Rxsight Tech Stack
A closer look at the technologies used by Rxsight
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Rxsight News & Media
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D., who will continue to serve as Chief Medical Officer.RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
RxSight (NASDAQ:RXST) reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustabRxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Q2 2026 Earnings Call July 7, 2026 8:00 AM EDTCompany ParticipantsOliver Moravcevic - Vice President of Investor RelationsRonald Kurtz...RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the company’s strategic collaboration with Alcon to develop and commercialize light-adjustable Presbyopia-Correcting Intraocular Lenses.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rxsight
Sign Up For FreeTo access detailed company insights
RxSight enables doctors and patients to predictably optimize vision after cataract surgery through an office-based IOL enhancement. RxSight was founded in 1997 and is headquartered in California.... Read More
